Description
This episode treats of the Hepahealth II study, which aimed at estimating the impact of policy interventions targeting alcohol and obesity on the incidence of chronic liver disease and primary liver cancer in three European countries. Join our experts in their discussion of this study and of its conclusions.
Faculty
- Patrizia Burra (Moderator)
- Maria Buti (Faculty)
- Peter Jepsen (Faculty)
- Shira Zelber-Sagi (Faculty)
Related episodes
- EASL Studio S6E1: Do we solve MASLD by treating obesity?
- EASL Studio from EASL Congress 2023: The battle to reduce alcohol harms… EASL’s new policy
- EASL Studio S4E8: The central role of alcohol and food policies on liver health
- EASL Studio S2E2: Fats or carbs, who is the real villain?
ℹ️ Please click here to access the podcast version of this EASL Studio episode.